MetLife Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $732K | Hold |
11,219
| – | – | ﹤0.01% | 1476 |
|
2025
Q1 | $751K | Sell |
11,219
-178
| -2% | -$11.9K | ﹤0.01% | 1509 |
|
2024
Q4 | $630K | Buy |
11,397
+675
| +6% | +$37.3K | ﹤0.01% | 1674 |
|
2024
Q3 | $640K | Hold |
10,722
| – | – | ﹤0.01% | 1648 |
|
2024
Q2 | $683K | Buy |
10,722
+3,046
| +40% | +$194K | ﹤0.01% | 1548 |
|
2024
Q1 | $531K | Hold |
7,676
| – | – | ﹤0.01% | 1641 |
|
2023
Q4 | $423K | Hold |
7,676
| – | – | ﹤0.01% | 1792 |
|
2023
Q3 | $446K | Buy |
7,676
+950
| +14% | +$55.2K | ﹤0.01% | 1708 |
|
2023
Q2 | $362K | Hold |
6,726
| – | – | ﹤0.01% | 1908 |
|
2023
Q1 | $267K | Buy |
6,726
+288
| +4% | +$11.4K | ﹤0.01% | 2046 |
|
2022
Q4 | $259K | Buy |
6,438
+580
| +10% | +$23.3K | ﹤0.01% | 2087 |
|
2022
Q3 | $188K | Hold |
5,858
| – | – | ﹤0.01% | 2337 |
|
2022
Q2 | $174K | Hold |
5,858
| – | – | ﹤0.01% | 2415 |
|
2022
Q1 | $165K | Buy |
5,858
+2,127
| +57% | +$59.8K | ﹤0.01% | 2470 |
|
2021
Q4 | $172K | Hold |
3,731
| – | – | ﹤0.01% | 2152 |
|
2021
Q3 | $122K | Buy |
+3,731
| New | +$122K | ﹤0.01% | 2350 |
|
2021
Q1 | – | Sell |
-3,945
| Closed | -$115K | – | 2314 |
|
2020
Q4 | $115K | Hold |
3,945
| – | – | ﹤0.01% | 2213 |
|
2020
Q3 | $111K | Hold |
3,945
| – | – | ﹤0.01% | 2168 |
|
2020
Q2 | $128K | Hold |
3,945
| – | – | ﹤0.01% | 2139 |
|
2020
Q1 | $161K | Hold |
3,945
| – | – | ﹤0.01% | 1812 |
|
2019
Q4 | $243K | Hold |
3,945
| – | – | ﹤0.01% | 1878 |
|
2019
Q3 | $288K | Hold |
3,945
| – | – | ﹤0.01% | 1729 |
|
2019
Q2 | $324K | Hold |
3,945
| – | – | ﹤0.01% | 1750 |
|
2019
Q1 | $278K | Hold |
3,945
| – | – | ﹤0.01% | 1797 |
|
2018
Q4 | $178K | Hold |
3,945
| – | – | ﹤0.01% | 1975 |
|
2018
Q3 | $223K | Hold |
3,945
| – | – | ﹤0.01% | 2024 |
|
2018
Q2 | $264K | Hold |
3,945
| – | – | ﹤0.01% | 1781 |
|
2018
Q1 | $230K | Hold |
3,945
| – | – | ﹤0.01% | 1811 |
|
2017
Q4 | $254K | Buy |
+3,945
| New | +$254K | ﹤0.01% | 1800 |
|